Aureus Pharma Announces Date of 2008 Annual User Symposium
Published: Jul 03, 2008
PARIS, July 2 /PRNewswire/ -- Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life science industry, announced today that the Aureus Pharma 2008 User Symposium will be held in Paris on October 23rd and 24th.
This symposium follows last year's highly successful inaugural event which was attended by many of Aureus' pharmaceutical and biotech customers from both Europe and North America. The symposium included presentations from industry scientists who described their experience and value perception of Aureus' solutions as applied to their discovery research projects. In addition, challenges and requirements for future developments were discussed.
At the 2008 event, Aureus will introduce several new products and services as well as provide users and prospective users with a better understanding of how Aureus technology can be beneficially implemented within their individual organizations.
"The first Aureus Pharma User Symposium was a great opportunity for our customers to discuss and share the benefits of their respective experiences related to knowledge driven discovery," said Jason Theodosiou, President & CEO of Aureus Pharma. "I am looking forward to this year's meeting as a continued dialog to direct and to improve Aureus Pharma's contribution to the life science industry."
For more information regarding Aureus Pharma's 2008 User Symposium, please visit http://www.aureus-pharma.com
About Aureus Pharma
Aureus Pharma headquartered in Paris, France is a privately held knowledge management based solutions provider for the life sciences industry. Aureus Pharma accelerates new drug discovery by providing knowledge databases which contain high quality quantitative information for both chemistry and biology. Researchers gain rapid access to knowledge for important drug target classes including GPCR, Ion Channel, Kinase as well as other critical pharmaceutical topics including ADME/Drug-Drug Interactions and the hERG Channel. The information contained in the Aureus Pharma system is of primary importance to aid in lead discovery and optimization as well as to build predictive models. For further information on how Aureus Pharma helps researchers turn data into discovery visit http://www.aureus-pharma.com
CONTACT: Media Contact: Mary Donlan, Director of Marketing, Aureus Pharma,
Phone : +33-1-40-18-57-59/+33-6-76-19-51-77, email@example.com